glp-1 drugs and dementia How GLP-1s Could Transform Alzheimer's Treatment Could GLP‑1 Weight‑Loss Drugs Help
Description
Lilly's oral GLP-1, orforglipron, demonstrated meaningful weight loss and cardiometabolic improvements in complete ATTAIN-1 results published in The New England Journal of Medicine [press release]
doi: 10.1002/hep.23569
(2019) Free fatty acid receptors, G protein-coupled receptor 120 and G protein-coupled receptor 40, are essential for oil-induced gastric inhibitory polypeptide secretion
(2025) 39:e70392
individuals with diabetes from 2015 to 2019, lower GLP-1 use was seen among Asian, Black, and Hispanic, compared with White, individuals and among those living in lower versus higher income households [229]
